Cargando…
Remdesivir Inhibits Tubulointerstitial Fibrosis in Obstructed Kidneys
Aim: Kidney impairment is observed in patients with COVID-19. The effect of anti-COVID-19 agent remdesivir on kidneys is currently unknown. We aimed to determine the effect of remdesivir on renal fibrosis and its downstream mechanisms. Methods: Remdesivir and its active nucleoside metabolite GS-4415...
Autores principales: | Xu, Lin, Tan, Bo, Huang, Di, Yuan, Meijie, Li, Tingting, Wu, Ming, Ye, Chaoyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8284048/ https://www.ncbi.nlm.nih.gov/pubmed/34276356 http://dx.doi.org/10.3389/fphar.2021.626510 |
Ejemplares similares
-
Protein arginine methyltransferase 3 inhibits renal tubulointerstitial fibrosis through asymmetric dimethylarginine
por: Wang, Yanzhe, et al.
Publicado: (2022) -
SDMA attenuates renal tubulointerstitial fibrosis through inhibition of STAT4
por: Wang, Yanzhe, et al.
Publicado: (2023) -
Rhubarb Protect Against Tubulointerstitial Fibrosis by Inhibiting TGF-β/Smad Pathway and Improving Abnormal Metabolome in Chronic Kidney Disease
por: Zhang, Zhi-Hao, et al.
Publicado: (2018) -
Progression of Tubulointerstitial Fibrosis and the Chronic Kidney Disease Phenotype – Role of Risk Factors and Epigenetics
por: Hewitson, Timothy D., et al.
Publicado: (2017) -
Salvianolic acid B attenuates tubulointerstitial fibrosis by inhibiting EZH2 to regulate the PTEN/Akt pathway
por: Lin, Pinglan, et al.
Publicado: (2022)